S Sridhar resigns as MD of Pfizer
New Delhi: Drug firm Pfizer has announced that its Managing Director S Sridhar has resigned from the company. Sridhar has expressed his intention to take early retirement and has tendered his resignation, the company said in a regulatory filing.
He will continue to serve in his current position until the identification, selection and transition to the new leadership takes place in the company, it added.
Over the past 14 years, Sridhar has led a number of key leadership positions in Pfizer, including serving as the Chief Financial Officer for a period of eight years.
Read also: Pfizer to purchase Global Blood Therapeutics for USD 5.4 Billion
Over the past six years, he has led Pfizer as Managing Director and made significant contributions to the growth of the company's portfolio and presence across India, the drug firm stated.
Sridhar has also served as the Co-Chair of the FICCI Pharmaceuticals Committee and currently also serves as the President of the Organization of Pharmaceuticals Producers of India (OPPI).
Read also: Israel Makov to step down as Sun Pharma Chairman
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.